According to @Honest_Medicine, Dr. Molly Rutherford, Senior Fellow at the Independent Medical Alliance, stated that the recent safety signals regarding mRNA COVID-19 vaccines are catastrophic and comparable to situations where the FDA historically removed drugs from the market (source: Twitter/@Honest_Medicine, May 20, 2025). This development has led to increased volatility in biotech stocks, with investors closely watching for potential regulatory actions. Crypto traders are also monitoring sentiment shifts, as negative news from the pharmaceutical sector can spur safe-haven flows into digital assets and impact correlated tokens like Bionomics (BNOX) and medical AI-related cryptocurrencies.